GRAIL Inc GRAL
News
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update
Wheels Up Announces Gregory Summe to Join Board of Directors
GRAIL to Announce Second Quarter 2024 Financial Results
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population
GRAIL Advances the Galleri® Registrational Clinical Trial Program